Skip to content

Cartalax

Synthetic tripeptide bioregulator targeting cartilage and connective tissue. Reduces senescence markers (p16, p21, p53), increases SIRT6, promotes cartilage regeneration. Sequence: Ala-Glu-Asp.

Intelligence Profile

Safety Profile

Evidence Limitation Warning: The safety profile for Cartalax is extremely limited, as no human clinical trials or dedicated safety studies were found in the available literature. The safety assessment is based solely on preclinical research conducted in cell cultures and laboratory settings.

Known Side Effects

No human side effects data is available. The retrieved studies focused exclusively on cellular effects in laboratory cultures of stem cells, fibroblasts, kidney tissue, and thymocytes. None of these studies reported adverse cellular effects, but this cannot be extrapolated to predict human tolerance or safety.

Contraindications

No established contraindications exist due to the absence of human clinical data. Without proper safety studies, contraindications cannot be determined.

Drug Interactions

No drug interaction data is available. The potential for Cartalax to interact with medications, supplements, or other therapies has not been studied.

Populations That Should Avoid Use

Given the complete lack of human safety data:

  • All populations should exercise extreme caution
  • Pregnant and breastfeeding women should avoid use due to unknown effects on fetal development and infant safety
  • Children and adolescents should avoid use as safety in developing individuals is unknown
  • Individuals with chronic medical conditions should avoid use without medical supervision
  • Elderly populations should use caution despite some studies focusing on aging-related cellular processes

Critical Safety Considerations

The available research consists entirely of in vitro (test tube/cell culture) studies examining cellular effects. This type of preclinical research cannot predict human safety, tolerability, appropriate dosing, or potential adverse reactions. The leap from cellular studies to human use involves significant unknowns.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Consult a healthcare provider before considering any therapeutic compound, especially one lacking established human safety data.

Free account required

Safety profile requires a free AXIFI account to access clinical data, safety profiles, and research papers.